News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
766,560 Results
Type
Article (58333)
Company Profile (401)
Press Release (707826)
Section
Business (221282)
Career Advice (2928)
Deals (38069)
Drug Delivery (118)
Drug Development (87181)
Employer Resources (191)
FDA (17360)
Job Trends (16390)
News (375114)
Policy (36388)
Tag
Academia (2933)
Alliances (54309)
Alzheimer's disease (1393)
Approvals (17294)
Artificial intelligence (207)
Bankruptcy (381)
Best Places to Work (12388)
Biotechnology (260)
Breast cancer (217)
Cancer (1661)
Cardiovascular disease (136)
Career advice (2461)
CAR-T (124)
Cell therapy (352)
Clinical research (69621)
Collaboration (638)
Compensation (318)
COVID-19 (2795)
C-suite (149)
Data (1531)
Diabetes (205)
Diagnostics (6674)
Earnings (89401)
Employer resources (165)
Events (121619)
Executive appointments (533)
FDA (18183)
Funding (558)
Gene therapy (251)
GLP-1 (738)
Government (4862)
Healthcare (20375)
Infectious disease (2900)
Inflammatory bowel disease (127)
Interviews (559)
IPO (17190)
Job creations (4464)
Job search strategy (2045)
Layoffs (489)
Legal (9008)
Lung cancer (251)
Manufacturing (240)
Medical device (14190)
Medtech (14195)
Mergers & acquisitions (21152)
Metabolic disorders (568)
Neuroscience (1808)
NextGen: Class of 2025 (7279)
Non-profit (4954)
Northern California (1931)
Obesity (325)
Opinion (244)
Patents (146)
People (62587)
Phase I (21570)
Phase II (30488)
Phase III (22863)
Pipeline (638)
Postmarket research (3029)
Preclinical (9386)
Radiopharmaceuticals (259)
Rare diseases (324)
Real estate (6782)
Regulatory (24248)
Research institute (2611)
Resumes & cover letters (462)
Southern California (1682)
Startups (4028)
United States (17763)
Vaccines (667)
Weight loss (244)
Date
Today (149)
Last 7 days (632)
Last 30 days (2408)
Last 365 days (36934)
2025 (2326)
2024 (37335)
2023 (42277)
2022 (53494)
2021 (58216)
2020 (57059)
2019 (50438)
2018 (38285)
2017 (35332)
2016 (35537)
2015 (41637)
2014 (35745)
2013 (31154)
2012 (33192)
2011 (33819)
2010 (32465)
Location
Africa (986)
Arizona (226)
Asia (44856)
Australia (7871)
California (4466)
Canada (1601)
China (387)
Colorado (205)
Connecticut (220)
Europe (98523)
Florida (631)
Georgia (161)
Illinois (476)
Indiana (262)
Maryland (733)
Massachusetts (3503)
Michigan (206)
Minnesota (338)
New Jersey (1263)
New York (1274)
North Carolina (887)
Northern California (1931)
Ohio (162)
Pennsylvania (1037)
South America (1374)
Southern California (1682)
Texas (662)
Utah (131)
Washington State (456)
766,560 Results for "sonoma pharmaceuticals formerly known as oculus innovative sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) today announced that it will be presenting at two upcoming investor conferences in Denver and New York.
March 28, 2024
·
4 min read
Business
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
NovaBay Pharmaceuticals, Inc. and Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) today announced an agreement for the sale and marketing of Avenova branded products by Sonoma in the European Union.
January 9, 2024
·
6 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores
Sonoma Pharmaceuticals, Inc. today announced the launch of its MicrocynAH animal health care products in the Menards chain of home improvement stores in the United States.
May 9, 2024
·
4 min read
Business
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results
Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA),a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants, today announced financial results for fiscal year 2024 and the fourth quarter ended March 31, 2024.
June 17, 2024
·
11 min read
Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States
Sonoma Pharmaceuticals, Inc. today announced the expansion of its Microcyn Negative-Pressure Wound Therapy (NPWT) Solution products in the United States.
April 9, 2024
·
4 min read
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections
Sonoma Pharmaceuticals, Inc. reported a recent publication in the journal Neurourology and Urodynamics highlighting the potential for Microdox in the management of urinary tract infections.
April 4, 2024
·
5 min read
Press Releases
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
November 1, 2024
·
4 min read
Press Releases
Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States
November 22, 2024
·
4 min read
Press Releases
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results
November 7, 2024
·
13 min read
1 of 76,656
Next
